Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications

5 Aug 2021

Abstract excerpt

Atherosclerosis represents one of the major causes of death globally. The high mortality rates and limitations of current therapeutic modalities have urged researchers to explore potential alternative therapies. The clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR/Cas9) system is commonly deployed for investigating the genetic aspects of Atherosclerosis. Besides, advances in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Innovation and Socioeconomic Development
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34445123
DOI: 10.3390/ijms22168422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic ApplicationsPMID 34445123Read ↗

CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.Semantic proximity Read ↗

Gene editing therapy for cardiovascular diseasesSemantic proximity Read ↗

CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseasesSemantic proximity Read ↗

The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A Comprehensive Review of Current Progress and Future ProspectiveSemantic proximity Read ↗

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular researchSemantic proximity Read ↗

CRISPR-Cas9 Applications in Cardiovascular Disease.Semantic proximity Read ↗

Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.Semantic proximity Read ↗

CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and OpportunitiesSemantic proximity Read ↗

CRISPR and cardiovascular diseasesSemantic proximity Read ↗

Gene editing in common cardiovascular diseasesSemantic proximity Read ↗

Genome Editing for the Study of Cardiovascular Diseases.Semantic proximity Read ↗

CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.